{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:04:52Z","timestamp":1784912692143,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.neuropharm.2011.07.025","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T14:45:09Z","timestamp":1313246709000},"page":"1256-1264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats"],"prefix":"10.1016","volume":"61","author":[{"given":"Epolia","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Basselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Y.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewon","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.07.025_bib1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF01291783","article-title":"Interactions between dopamine and GABA in the control of ambulatory activity","volume":"103","author":"Agmo","year":"1996","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-004-1008-4","article-title":"Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats","volume":"371","author":"Ahmad","year":"2005","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","article-title":"Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients","volume":"157","author":"Anand","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10673229609017200","article-title":"Brain dopamine receptors: a primer on their current status, basic and clinical","volume":"3","author":"Baldessarini","year":"1996","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.npp.1300671","article-title":"Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid","volume":"30","author":"Basselin","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","article-title":"Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats","volume":"31","author":"Basselin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1471-4159.2005.03612.x","article-title":"Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mice","volume":"96","author":"Basselin","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2007.04.021","article-title":"Chronic carbamazepine administration reduces NMDA receptor-initiated signaling via arachidonic acid in rat brain","volume":"62","author":"Basselin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib9","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11064-007-9372-3","article-title":"Flurbiprofen, a cyclooxygenase inhibitor, reduces the brain arachidonic acid signal in response to the cholinergic muscarinic, arecoline, in awake rats","volume":"32","author":"Basselin","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib10","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11064-008-9700-2","article-title":"Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats","volume":"33","author":"Basselin","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11064-008-9595-y","article-title":"Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain","volume":"33","author":"Basselin","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00213-005-0059-7","article-title":"Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat","volume":"1","author":"Bazinet","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00213-005-0272-4","article-title":"Valproic acid selectively inhibits conversion of arachidonic acid to arachionoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder","volume":"184","author":"Bazinet","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2005.07.024","article-title":"Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder","volume":"59","author":"Bazinet","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib15","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib16","first-page":"1110011","article-title":"A\u00a0role of Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health","volume":"36","author":"Beaulieu","year":"2011","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj2490513","article-title":"Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes","volume":"249","author":"Bellringer","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.mp.4001758","article-title":"The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia","volume":"11","author":"Benes","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0306-4522(85)90248-9","article-title":"New dopaminergic terminal fields in the motor, visual (area 18b) and retrosplenial cortex in the young and adult rat. Immunocytochemical and catecholamine histochemical analyses","volume":"15","author":"Berger","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00213-005-2208-4","article-title":"D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats","volume":"180","author":"Bhattacharjee","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib22","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.jcbfm.9600290","article-title":"D-Amphetamine stimulates D2 dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats","volume":"26","author":"Bhattacharjee","year":"2006","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-008-1073-3","article-title":"Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats","volume":"197","author":"Bhattacharjee","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0006-8993(75)90849-5","article-title":"Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals","volume":"83","author":"Bjorklund","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.mp.4001111","article-title":"Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain","volume":"7","author":"Bosetti","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-4159.2003.01701.x","article-title":"Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain","volume":"85","author":"Bosetti","year":"2003","journal-title":"J.\u00a0Neurochem."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2011.07.025_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-5618.2009.00708.x","article-title":"Anticonvulsants in bipolar disorders: current research and practice and future directions","volume":"11","author":"Bowden","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-d-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1471-4159.2001.00311.x","article-title":"Chronic valproate treatment decreases the in\u00a0vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers","volume":"77","author":"Chang","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(96)13264-X","article-title":"Lithium decreases turnover of arachidonate in several brain phospholipids","volume":"220","author":"Chang","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib32","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1046\/j.1471-4159.1994.63062361.x","article-title":"Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in\u00a0vitro","volume":"63","author":"Chen","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1471-4159.1999.720879.x","article-title":"The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS","volume":"72","author":"Chen","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib119","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2011.07410.x","article-title":"Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain","author":"Cheon","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib35","first-page":"CD004362","article-title":"Haloperidol alone or in combination for acute mania","volume":"3","author":"Cipriani","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0929-7855(95)00012-F","article-title":"Cytosolic phospholipase A2","volume":"12","author":"Clark","year":"1995","journal-title":"J.\u00a0Lipid Mediat. Cell Signal."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.09.088","article-title":"Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation","volume":"1247","author":"D\u2019Souza","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib39","first-page":"178","article-title":"The effect of vigabatrin, lamotrigine and gabapentin on the fertility, weights, sex hormones and biochemical profiles of male rats","volume":"25","author":"Daoud","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.490240311","article-title":"Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats","volume":"24","author":"DeGeorge","year":"1989","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbalip.2006.06.006","article-title":"Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats","volume":"1761","author":"Demar","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0010-440X(92)90007-D","article-title":"The role of dopamine in mood disorders","volume":"33","author":"Diehl","year":"1992","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib44","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib45","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1194\/jlr.M800200-JLR200","article-title":"Formation of eicosanoids, E2\/D2-isoprostanes and docosanoids following decapitation-induced ischemia, measured in high-energy microwaved rat brain","volume":"49","author":"Farias","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib46","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1007\/s11064-008-9693-x","article-title":"Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction","volume":"33","author":"Feng","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A\u00a0simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2006.01.002","article-title":"Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania","volume":"79","author":"Frey","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopsych.2004.05.012","article-title":"Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain","volume":"56","author":"Ghelardoni","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-005-2189-3","article-title":"Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism","volume":"180","author":"Ghelardoni","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib51","first-page":"1471","article-title":"Brain incorporation of [11C]arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction","volume":"45","author":"Giovacchini","year":"2004","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1996.6381","article-title":"New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists","volume":"144","author":"Goetz","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib53","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1152\/jn.00361.2010","article-title":"Regulation of inhibitory synapses by presynaptic D4 dopamine receptors in thalamus","volume":"104","author":"Govindaiah","year":"2010","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","article-title":"Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder","volume":"105","author":"Greenwood","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.mp.4001764","article-title":"Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples","volume":"11","author":"Greenwood","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(00)00196-0","article-title":"Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels","volume":"43","author":"Hassel","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib57","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0022-3565(24)38853-6","article-title":"Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson\u2019s disease","volume":"296","author":"Hayakawa","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","article-title":"Altered gene expression of histone deacetylase in mood disorder patients","volume":"44","author":"Hobara","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/07315724.1986.10720125","article-title":"Control of polyunsaturated acids in tissue lipids","volume":"5","author":"Holman","year":"1986","journal-title":"J.\u00a0Am. Coll. Nutr."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib60","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.mp.4001730","article-title":"A\u00a0dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression","volume":"10","author":"Horschitz","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s002130000677","article-title":"Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion","volume":"154","author":"Horvitz","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wnf.0000154220.30263.0e","article-title":"Temporal dynamics of cortical and subcortical responses to apomorphine in Parkinson disease: an H2(15)O PET study","volume":"28","author":"Hosey","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib63","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.pnpbp.2007.04.013","article-title":"Immunohistochemical and immunoblot analysis of dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder","volume":"31","author":"Ishikawa","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib64","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1523\/JNEUROSCI.22-19-08476.2002","article-title":"Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor","volume":"22","author":"Kabbani","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2199-3-16","article-title":"Cyclooxygenase-2 is a neuronal target gene of NF-\u03baB","volume":"3","author":"Kaltschmidt","year":"2002","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant\u2019Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/mp.2009.137","article-title":"Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients","volume":"16","author":"Kim","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib68","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nbd.2009.11.010","article-title":"Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib69","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.mp.4001471","article-title":"Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium","volume":"9","author":"Knable","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archpsyc.60.3.311","article-title":"Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia","volume":"60","author":"Koh","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11064-005-2756-3","article-title":"Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat","volume":"30","author":"Lee","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib73","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)10937-3","article-title":"Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain","volume":"262","author":"Levant","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib74","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1517\/14656566.2010.510835","article-title":"Atypical antipsychotic tolerability and switching strategies in bipolar disorder","volume":"11","author":"Liauw","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib75","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1073\/pnas.86.16.6412","article-title":"Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride","volume":"86","author":"Lidow","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib76","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0278-5846(93)90049-X","article-title":"The effects of valproate in brain monoamines of juvenile rats after stress","volume":"17","author":"Mitsikostas","year":"1993","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib78","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1471-4159.2005.03654.x","article-title":"The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents","volume":"96","author":"Montezinho","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","article-title":"Valproic acid is neuroprotective in the rotenone rat model of Parkinson\u2019s disease: involvement of alpha-synuclein","volume":"17","author":"Monti","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib81","doi-asserted-by":"crossref","first-page":"49533","DOI":"10.1074\/jbc.M408319200","article-title":"Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor","volume":"279","author":"Namkung","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib82","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/sj.bjp.0702025","article-title":"Direct dopamine D2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+-mobilizing agent","volume":"124","author":"Nilsson","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0006-3223(93)90157-9","article-title":"Elevated PLA2 activity in schizophrenics and other psychiatric patients","volume":"34","author":"Noponen","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib84","first-page":"391","article-title":"Distribution of cytoplasmic phospholipase A2 in the normal rat brain","volume":"39","author":"Ong","year":"1999","journal-title":"J.\u00a0Hirnforsch."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib85","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1987"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In\u00a0vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib87","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2165\/00002018-199512020-00007","article-title":"Drug-induced mania","volume":"12","author":"Peet","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","article-title":"Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia","volume":"134","author":"Peng","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib89","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib90","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01953694","article-title":"Brain prostaglandin content in rats sacrificed by decapitation vs focused microwave irradiation","volume":"38","author":"Poddubiuk","year":"1982","journal-title":"Experientia"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib91","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0006-3223(02)01489-0","article-title":"Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system","volume":"53","author":"Ralph-Williams","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib92","first-page":"1","article-title":"Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat\u00a0brain: implications for its efficacy in bipolar disorder","volume":"28","author":"Ramadan","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1399-5618.2007.00361.x","article-title":"Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kB DNA binding activity and COX-2 mRNA","volume":"9","author":"Rao","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib94","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biopsych.2006.03.029","article-title":"Chronic administration of carbamazepine downregulates AP-2 DNA binding activity and AP-2a protein expression in rat frontal cortex","volume":"61","author":"Rao","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib95","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.npp.1300740","article-title":"Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks","volume":"30","author":"Rao","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib96","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jn\/138.12.2515","article-title":"Arachidonic acid and the brain","volume":"138","author":"Rapoport","year":"2008","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib97","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanism of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib98","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-2275(20)31629-1","article-title":"Delivery and turnover of plasma-derived essential PUFAs in mammalian brain","volume":"42","author":"Rapoport","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib99","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib100","first-page":"25","article-title":"Biological effects of lysophospholipids","volume":"160","author":"Rivera","year":"2008","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-0173(92)90016-F","article-title":"A\u00a0quantitative method for measuring regional in\u00a0vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis","volume":"17","author":"Robinson","year":"1992","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s007020200035","article-title":"Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder","volume":"109","author":"Shaldubina","year":"2002","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib104","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.schres.2006.07.015","article-title":"Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from clinical population","volume":"88","author":"Sharma","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbalip.2010.12.006","article-title":"Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproates\u2019 efficacy against bipolar disorder","volume":"1811","author":"Shimshoni","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","article-title":"Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis","volume":"122","author":"Smith","year":"2010","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib107","series-title":"Computer-assisted Research Design and Analysis","author":"Tabachnick","year":"2001"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib109","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1046\/j.1471-4159.1995.64062765.x","article-title":"Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonic-specific phospholipase A2","volume":"64","author":"Vial","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpsychires.2007.03.005","article-title":"Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania","volume":"42","author":"Walz","year":"2008","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib111","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1471-4159.2005.03051.x","article-title":"Sp1 and Sp3 activate transcription of the human dopamine transporter gene","volume":"93","author":"Wang","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib112","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1460-9568.2007.05460.x","article-title":"Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib113","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jad.2009.10.021","article-title":"Divalproex extended-release in acute bipolar II depression","volume":"124","author":"Wang","year":"2010","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib114","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1523\/JNEUROSCI.23-30-09852.2003","article-title":"Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex","volume":"23","author":"Wang","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/dna.1998.17.471","article-title":"Sp family transcription factors regulate expression of rat D2 dopamine receptor gene","volume":"17","author":"Yajima","year":"1998","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.neuropharm.2011.07.025_bib116","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib117","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1176\/appi.ajp.159.10.1718","article-title":"PET study of the effects of valproate on dopamine D2 receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania","volume":"159","author":"Yatham","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.07.025_bib118","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2990.2010.01128.x","article-title":"Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder","volume":"37","author":"Zhan","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:25:41Z","timestamp":1784910341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811003030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":119,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0028390811003030"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}